Literature DB >> 22077201

Nanosuspensions in drug delivery: recent advances, patent scenarios, and commercialization aspects.

Sandip S Chavhan1, Kailash C Petkar, Krutika K Sawant.   

Abstract

The interest in the preparation and application of nanometer-sized materials is increasing due to their tremendous potential as a drug delivery system with wide range of applications. Recently, nanoscale systems have received much interest as a way to resolve solubility issues because of their cost-effectiveness and technical simplicity compared to liposomes and other colloidal drug carriers. Nanosuspensions have proven to be a better alternative over other approaches currently available for improving bioavailability of number of drugs with low solubility. Nanosuspensions have been extensively developed for a wide range of drugs and have been evaluated for in vitro and in vivo applications by various routes: parenteral, oral, pulmonary, topical. They have also been used for drug targeting. Different preparation methods for nanosuspensions and their application are being reported and patented. In fact, the number of products based on nanosuspension in the market and under clinical study is higher than that of other nanotechnology-based applications. This article reviews the research and recent advances in formulation, characterization, application of nanosuspensions as well as patents on nanosuspension methods.

Mesh:

Substances:

Year:  2011        PMID: 22077201     DOI: 10.1615/critrevtherdrugcarriersyst.v28.i5.20

Source DB:  PubMed          Journal:  Crit Rev Ther Drug Carrier Syst        ISSN: 0743-4863            Impact factor:   4.889


  4 in total

1.  Preparation of Nanocrystals for Insoluble Drugs by Top-Down Nanotechnology with Improved Solubility and Bioavailability.

Authors:  Xun Zhang; Zhiguo Li; Jing Gao; Zengming Wang; Xiang Gao; Nan Liu; Meng Li; Hui Zhang; Aiping Zheng
Journal:  Molecules       Date:  2020-02-28       Impact factor: 4.411

Review 2.  Innovative pharmaceutical development based on unique properties of nanoscale delivery formulation.

Authors:  Anil Kumar; Fei Chen; Anbu Mozhi; Xu Zhang; Yuanyuan Zhao; Xiangdong Xue; Yanli Hao; Xiaoning Zhang; Paul C Wang; Xing-Jie Liang
Journal:  Nanoscale       Date:  2013-09-21       Impact factor: 7.790

3.  Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique.

Authors:  Shuqi Li; Jie Zhang; Yuqi Fang; Jun Yi; Zhufen Lu; Yanzhong Chen; Bohong Guo
Journal:  Drug Des Devel Ther       Date:  2020-01-16       Impact factor: 4.162

4.  Preparation and characterisation of nevirapine oral nanosuspensions.

Authors:  Anju Raju; A Jagdeesh Reddy; J Satheesh; A V Jithan
Journal:  Indian J Pharm Sci       Date:  2014-01       Impact factor: 0.975

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.